Stem Cells and COVID-19
-10%
portes grátis
Stem Cells and COVID-19
Sharma, Chandra P.; Thankam, Finosh G.; Agrawal, Devendra K.
Elsevier Science & Technology
04/2022
248
Mole
Inglês
9780323899727
15 a 20 dias
450
Descrição não disponível.
1. Introduction
2. Characteristics and Immunobiology of COVID19
3. Molecular Mechanism and translation approaches
4. Inflammatory multisystem syndrome in COVID19: Insights on off-target organ system in susceptible and recovering population
5. Cytokine storm and stem cell activation in unveiling potential targets for diagnosis and therapy
6. Mesenchymal and hematopoietic stem cells: Novel avenues in combating COVID19
7. Immunomodulatory properties of mesenchymal and hematopoietic stem cells - potential therapeutic target for COVID-19
8. COVID19 and acute myocardial injury: Stem cell driven tissue remodeling in COVID19 infection
9. Stem cell born signals and tissue regeneration in COVID19 infection
10. Stem cell transplantation COVID19 management: Translational possibilities and future
11. Therapeutic scale stem cell-derived exosomes for COVID - 19: Models - Validation, Management & Strategies
12. Therapy: present & future clinical perspective
2. Characteristics and Immunobiology of COVID19
3. Molecular Mechanism and translation approaches
4. Inflammatory multisystem syndrome in COVID19: Insights on off-target organ system in susceptible and recovering population
5. Cytokine storm and stem cell activation in unveiling potential targets for diagnosis and therapy
6. Mesenchymal and hematopoietic stem cells: Novel avenues in combating COVID19
7. Immunomodulatory properties of mesenchymal and hematopoietic stem cells - potential therapeutic target for COVID-19
8. COVID19 and acute myocardial injury: Stem cell driven tissue remodeling in COVID19 infection
9. Stem cell born signals and tissue regeneration in COVID19 infection
10. Stem cell transplantation COVID19 management: Translational possibilities and future
11. Therapeutic scale stem cell-derived exosomes for COVID - 19: Models - Validation, Management & Strategies
12. Therapy: present & future clinical perspective
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
3D in vitro models; ACE2; ADAM-17; Antigen; ARDS; Bioengineering; Biomaterials; Cell-based therapy; Cell-free; Convalescent plasma therapy; Coronavirus; COVID; COVID-19; CVD; Cytokine storm; Cytokine storms; Drugs; Embryonic stem cells; Etiology; Hematopoietic stem cells; Human behavior; Human lung; Immune responses; Immunology; Immunomodulators; Incubation period; Infection; Infectious disease; Inflammation; Inflammatory multisystem syndrome; Interleukin; iPSC; Mesenchymal stem cells; Mesenchymal stromal; miRNAs; Molecular biology; New drugs; NK cells; Nucleocapsid; Pharmaceutical preparation; Postinfection; Proteins; Pulmonary; Respiratory syndrome; RNA viruses; SARS; SARS-CoV; SARS-COV II; SARS-Cov-2; SARS-CoV-2; SARS-CoV2 virus; Stem cell exosomes; Stem cell therapy; Stem cells; Tissue regeneration; Tissue-resident stem cells; TMPRSSs; TNFa; Vaccines; Virology
1. Introduction
2. Characteristics and Immunobiology of COVID19
3. Molecular Mechanism and translation approaches
4. Inflammatory multisystem syndrome in COVID19: Insights on off-target organ system in susceptible and recovering population
5. Cytokine storm and stem cell activation in unveiling potential targets for diagnosis and therapy
6. Mesenchymal and hematopoietic stem cells: Novel avenues in combating COVID19
7. Immunomodulatory properties of mesenchymal and hematopoietic stem cells - potential therapeutic target for COVID-19
8. COVID19 and acute myocardial injury: Stem cell driven tissue remodeling in COVID19 infection
9. Stem cell born signals and tissue regeneration in COVID19 infection
10. Stem cell transplantation COVID19 management: Translational possibilities and future
11. Therapeutic scale stem cell-derived exosomes for COVID - 19: Models - Validation, Management & Strategies
12. Therapy: present & future clinical perspective
2. Characteristics and Immunobiology of COVID19
3. Molecular Mechanism and translation approaches
4. Inflammatory multisystem syndrome in COVID19: Insights on off-target organ system in susceptible and recovering population
5. Cytokine storm and stem cell activation in unveiling potential targets for diagnosis and therapy
6. Mesenchymal and hematopoietic stem cells: Novel avenues in combating COVID19
7. Immunomodulatory properties of mesenchymal and hematopoietic stem cells - potential therapeutic target for COVID-19
8. COVID19 and acute myocardial injury: Stem cell driven tissue remodeling in COVID19 infection
9. Stem cell born signals and tissue regeneration in COVID19 infection
10. Stem cell transplantation COVID19 management: Translational possibilities and future
11. Therapeutic scale stem cell-derived exosomes for COVID - 19: Models - Validation, Management & Strategies
12. Therapy: present & future clinical perspective
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
3D in vitro models; ACE2; ADAM-17; Antigen; ARDS; Bioengineering; Biomaterials; Cell-based therapy; Cell-free; Convalescent plasma therapy; Coronavirus; COVID; COVID-19; CVD; Cytokine storm; Cytokine storms; Drugs; Embryonic stem cells; Etiology; Hematopoietic stem cells; Human behavior; Human lung; Immune responses; Immunology; Immunomodulators; Incubation period; Infection; Infectious disease; Inflammation; Inflammatory multisystem syndrome; Interleukin; iPSC; Mesenchymal stem cells; Mesenchymal stromal; miRNAs; Molecular biology; New drugs; NK cells; Nucleocapsid; Pharmaceutical preparation; Postinfection; Proteins; Pulmonary; Respiratory syndrome; RNA viruses; SARS; SARS-CoV; SARS-COV II; SARS-Cov-2; SARS-CoV-2; SARS-CoV2 virus; Stem cell exosomes; Stem cell therapy; Stem cells; Tissue regeneration; Tissue-resident stem cells; TMPRSSs; TNFa; Vaccines; Virology
